Mariëlle van Aalst et al. demonstrated that patients receiving TNF-α inhibitors as monotherapy had the best immune response to vaccination against pneumococcal infection compared to those prescribed DMARD [30]. This evidence concerns the gene TNF and pneumococcal infection.